Effects on aggregation of human platelets of two xanthines and their interactions with adenosine

Publisher Website
Google Scholar
Abstract
Adenosine receptor antagonism was suggested as the cellular basis for many extrapulmonary actions of xanthine derivatives, such as theophylline [used in the treatment of asthma]. Enprofylline (3-propylxanthine) is a poor adenosine antagonist but is 5 times as potent as theophylline as a bronchodilator in man. Adenosine is a potent inhibitor of platelet aggregation, but also xanthines are considered to exert this action. Effects of theophylline and enprofylline on ADP-induced aggregation of human platelets were studied in vitro. Theophylline alone in concentrations > 280 .mu.M inhibited platelet aggregation concentration-dependently. Enprofylline alone mimicked this effect but was .apprx. 5 times more potent than theophylline. At the lowest concentrations used, corresponding to upper therapeutic levels, neither of the 2 xanthines affected platelet aggregation by ADP. The interactions between these low concentrations of the xanthines and adenosine were then evaluated. In the presence of theophylline 110 .mu.M the inhibitory effect of adenosine 4 .mu.M was attenuated, whereas the presence of enprofylline 21 .mu.M enforced the inhibitory effect of adenosine. At low concentrations where neither theophylline nor enprofylline inhibits platelet aggregation theophylline antagonizes the antiaggregatory effect of adenosine, whereas enprofylline acts in synergy with this nucleoside.